QUOTE AND NEWS
newratings.com  Sep 27  Comment 
Patients lived average of 18 months without cancer progressing when taking Novartis' Zykadia(TM) as their first ALK inhibitor for ALK+ NSCLC Novartis International AG / Patients lived average of 18 months without cancer progressing when...
newratings.com  Sep 27  Comment 
Novartis drug Afinitor is first treatment for advanced pancreatic NET to provide overall survival of more than 3.5 years in Phase III trial Novartis International AG / Novartis drug Afinitor is first treatment for advanced pancreatic NET to...
newratings.com  Sep 26  Comment 
BRUSSELS (dpa-AFX) - Swiss stocks were little changed Friday as other European markets steadied after recent losses. The Swiss Market Index was up 0.02 percent to 8774.36, and is up almost 7 percent year-to-date despite this week's modest...
FiercePharma  Sep 26  Comment 
When Europe's drug approval gatekeepers meet, they often tick off recommendations for some key Big Pharma products. This week, the Committee for Medicinal Products for Human Use backed a whopping 15 new meds and 3 new indications.
newratings.com  Sep 26  Comment 
Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly Novartis International AG / Novartis drug Signifor® LAR recommended by CHMP for EU approval to treat patients with rare...
FierceBiotech  Sep 25  Comment 
Jockeying with a slew of next-generation treatments, Novartis' new anti-inflammatory drug succeeded in two Phase III trials on patients with psoriatic arthritis, stoking the company's hopes of snagging significant market share once it wins approval.
StreetInsider.com  Sep 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Novartis+%28NVS%29+Reports+Two+AIN457+Phase+3s+Met+Primary+Endpoints/9859746.html for the full story.
The Hindu Business Line  Sep 25  Comment 
Swiss drugmaker Novartis said two late-stage trials showed its drug secukinumab improved symptoms of psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes...
FiercePharma  Sep 24  Comment 
The U.S. drugmaker will build a new campus in New Jersey for about 2,500 that it promises will pump up "collaboration, creativity and innovation," much as Biogen Idec, Novartis and others have done before it.
The Hindu Business Line  Sep 19  Comment 
MNCs overseas hire 15% of their research hands from India




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki